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Abstract
Study Objectives: Prior research suggests that some individuals have a predisposition to experience insomnia following acute stressors
(i.e. sleep reactivity). The present study was a proof of concept and specifically aimed to provide additional empirical evidence that the link
between stressful life events and the onset of acute insomnia is moderated by sleep reactivity.
Methods: About 1,225 adults with a history of good sleep (Mage = 53.2 years, 68% female, 83% white) were recruited nationwide for an online
study on sleep health. Participants completed surveys to assess sleep reactivity (baseline), sleep patterns (daily sleep diary), and stressful life
events (weekly survey). All daily and weekly measures were completed for a one-year period. Sleep diary data were used to identify sleep
initiation/maintenance difficulties, including whether they met criteria for acute insomnia at any point during the one-year interval.
Results: Participants with high sleep reactivity compared to low sleep reactivity were at 76% increased odds of developing acute insomnia
during the one-year interval. In general, greater weekly stressful life events were associated with greater insomnia during the subsequent
week. Those participants with high sleep reactivity demonstrated a stronger relationship between weekly stressful life events and insomnia,
such that they reported the greatest levels of insomnia following weeks where they experienced a greater number of stressful life events.
Conclusions: These results further support the sleep reactivity model of insomnia, and specifically, provide evidence that sleep reactivity
predicts the incidence of acute insomnia in a sample of participants with no history of insomnia.

Statement of Significance
The current study used high-density data (daily/weekly measures) to track stressful life events and sleep, which allowed for a close examination of whether sleep reactivity predicts acute insomnia and how the association between stressful life events and sleep disturbance
varies as a function of sleep reactivity. Due to the high variability of stressful life events and sleep over time, frequent data points were
needed to test this etiological model of insomnia, and provide a proof of concept for sleep reactivity. Our findings have clinical utility for
establishing sleep reactivity as a potential target for prevention/intervention efforts for insomnia. Future studies could examine the effectiveness of minimizing the impact of stressful life events on sleep in individuals with high sleep reactivity.
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Introduction

Methods
Participants and procedure
This study was part of a larger parent study investigating the
incidence rates of acute and chronic insomnia in a sample of
initially good sleepers [20]. Two nationwide platforms (Zogby
Analytics and ResearchMatch) were used to recruit participants over three recruitment intervals, separated by approximately 1 year. The final sample included 1,225 participants
(Mage = 53.2 years, range = 27–89 years). The present sample was
primarily female (68%, n = 831) and white (83%, M = 1,019). The
study was conducted in two phases, described below. Please also
refer to the original paper [20] for additional details regarding
the sample.
Phase-1. A preliminary screener survey was administered through
Zogby (an international polling agency) and ResearchMatch to
identify participants without sleep disorders or a history of insomnia. Specifically, study candidates responded “yes” to the
following questions: “Are you a good sleeper? That is, do you reliably (5 or more nights per week) take less than 15 min to fall
asleep and are awake during the night for less than 15 min? Has
this been true for you for at least the last 6 months?”. These
screening criteria were conservative to increase the likelihood
that only persistently good sleepers were recruited. No other
inclusion or exclusion criteria were applied. Potential participants were then referred to the study website where they (1)
reviewed HIPPA forms and provided their informed consent, (2)
completed an intake survey (profiling sleep, health, and mental
health status and history), and (3) completed 2 weeks of online
sleep diaries (baseline assessment) to confirm their presentation as good sleepers.
Phase-2. Participants whose baseline sleep diary assessment reflected good sleep (i.e. SL ≤ 15 min and WASO ≤ 15 min, ≥ 5 nights
per week) were eligible for Phase-2 and were subsequently assessed for one year via an online study website. This site included
questionnaires that assessed: daily morning and evening sleep
diaries, weekly and bi-weekly instruments (e.g. medical symptoms checklist, stressful life events), and monthly instruments.
Participants were removed from the study for non-compliance
if their completion of online sleep diaries dropped below four
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Insomnia is a highly prevalent disorder with significant public
health and economic consequences. In fact, nearly 50% of adults
in the US experience insomnia at some point each year [1–4].
In addition, insomnia is associated with an increased risk for
numerous chronic disease outcomes [5], including cardiovascular disease [6], cancer [7, 8], and metabolic dysregulation [9].
Insomnia’s economic consequences are often calculated in
terms of direct and indirect costs, with a larger proportion of
the economic burden being attributed to indirect costs, particularly absenteeism (i.e. habitual pattern of unplanned absences
from work) and presenteeism (i.e. loss of productivity when employees are not fully functioning in the workplace) [10]. Based on
data collected from workers in the United States, annual losses
in work performance due to insomnia amount to nearly $91.7
billion [11]. These burdensome consequences highlight the need
for prevention and intervention efforts that are informed by a
better understanding of the factors that predispose and precipitate individuals to developing insomnia.
According to Spielman’s three-factor (or 3P) model of insomnia, the most common precipitating factors or triggering
events for insomnia are acute stressors. That said, the likelihood
or extent to which someone will experience a sleepless night
following a stressful life event varies by several factors, such as
the nature or severity of the stressor. The impact of stressful life
events on sleep also varies based on several individual factors,
also known as predisposing factors. Among other things, these
factors include a tendency toward cognitive or physiological
hyperarousal at night or in response to stress. This phenomenon
is also known as sleep reactivity, or a vulnerability to stressrelated sleep disturbance in response to real or perceived threat
[12]. Individuals with high sleep reactivity, regardless of whether
they have a current or past history of insomnia, are more likely
to experience difficulties with initiating or maintaining sleep
following a real or anticipated acute stressor (e.g. marital conflict or work-related acute stressors), relative to those with low
sleep reactivity [13–15]. These sleep reactive tendencies are considered stable over time and across different acute stressors (e.g.
job loss, death of a loved one, first night in a laboratory) [12].
Therefore, according to this diathesis-stress model of insomnia,
the combination of high sleep reactivity and a sufficiently
stressful event can potentially lead to more persistent insomnia
symptoms and even Insomnia Disorder [12, 13, 16, 17].
Multiple studies have now demonstrated, using longitudinal designs, that greater sleep reactivity predicts new onset
chronic insomnia or Insomnia Disorder (i.e. insomnia symptoms occurring at least 3 nights per week for 3 or more months).
This literature, however, has yet to definitively answer two
questions: (1) does sleep reactivity predict acute episodes of insomnia (i.e., symptoms present for less than 3 months) and (2)
does sleep reactivity moderate the association between stressful
life events and insomnia symptoms? The latter question provides a proof-of-concept for the sleep reactivity hypothesis of
insomnia. The primary issue is that past studies have not had
the temporal resolution to assess whether individuals with
greater sleep reactivity are more likely to experience acute bouts
of insomnia and whether those insomnia symptoms occur following an acute stressor. To do so, relatively high-density data
is needed to track stressful life events and insomnia symptoms
over time—e.g. at least weekly/monthly changes in stressful life

events and sleep. Although a previous study found that sleep
reactivity moderated the effects of stress on insomnia disorder
[12], the study measured stressful life events and sleep reactivity
annually. The conclusions that can be drawn from these data regarding acute sleep continuity disturbance are limited given that
both stressful life events and sleep are highly variable over time
[18, 19]. To address this limitation, the current study used a sampling strategy that allowed for a closer examination of whether
sleep reactivity predicts a greater incidence of acute insomnia
and how the week-to-week association between stressful life
events and insomnia varies as a function of sleep reactivity. We
hypothesized that individuals with high sleep reactivity will (1)
report a greater incidence of acute insomnia during a one-year
interval, and (2) be more likely to experience insomnia symptoms following a week with a greater number of self-reported
stressful life events.
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completed diaries per week across 2 weeks at any point during
the study. Noncompliance was monitored daily by study staff
and manually disenrolled from the study if they met criteria for
noncompliance.

Insomnia status. As reported previously [20], the one-year incidence of new-onset acute insomnia (AI) in this sample was
27.0% (n = 337). Each participant’s sleep diary data were used to
identify instances of sleep initiation and/or maintenance difficulties. Acute insomnia was defined as two consecutive weeks
with a frequency of ≥ 3 nights per week of sleep initiation and/
or maintenance complaints (sleep latency [SL] ≥ 30 min and/or
wake after sleep onset [WASO] ≥ 30 min and/or early morning
awakenings [EMA] ≥ 30 min) [21–23]. Of those that met criteria for AI, 72.4% (n = 244) of participants recovered good sleep
(AI-REC), and 6.8% (n = 23) developed chronic insomnia (CI). The
definition for recovery were at least 7 out of 12 weeks of “good”
sleep after an AI episode where the final 4 weeks in that period
were designated as “good” sleep (i.e. did not meet criteria for AI).
The definition for CI was 10 or more weeks in a 12-week period
with the same frequency and severity criteria as AI. Notably,
19.3% (n = 65) neither recovered nor went on to develop CI. This
group exhibited what might be best referred to as persistent
poor sleep (PPS; problems with sleep initiation or maintenance
[SL or WASO or EMA > 30 min] that did not meet or exceed frequency (3 or more days per week) or chronicity criteria (3 or
more months in duration).

Measures
Sleep reactivity. The Ford Insomnia Response to Stress Test (FIRST
[24]) is a 9-item questionnaire used to assess vulnerability to
stress-related sleep disturbance (i.e. sleep reactivity). Participants
completed the FIRST once during the baseline assessment (i.e.
start of Phase 2). The FIRST measures the probability that a
person would be to have difficulty sleeping following (or in anticipation of) a stressful situation. It asks how likely (1 = “not
likely”; 2 = “somewhat likely”; 3 = “moderately likely”; 4 = “very
likely”) the participant would have difficulty sleeping under
nine stressful situations (e.g. before an important meeting the
next day, after getting bad news during the day, after an argument, and before having to speak in public). Participants were
asked to rate the likelihood even if they had not experienced the

Daily sleep patterns. Sleep patterns were assessed via an online
daily sleep diary. Items included in the online sleep diary were
based on the Consensus Sleep Diary [28]. The diary was used
to measure daily fluctuations in sleep latency (SL), wake after
sleep onset (WASO), early morning awakenings (EMA), nocturnal awakenings (NWAK), time in bed (TIB), and total sleep
time (TST). SL measured time, in minutes and hours, to initial
sleep onset (i.e. “How long did it take you to fall asleep?”). WASO
measured how much time participants were “awake during the
night”. EMA values were reported in the sleep diaries as the
number of hours or minutes that the participant spent awake
in bed following their final awakening. Specifically, they were
asked, “What time was your final awakening?”, followed by
“How long were you continuously awake before getting out of
bed?”. TIB is estimated as the difference between “What time
did you get out of bed for the day?” and “What time did you try
and go to sleep?”. TST was assessed two ways: (1) subjective responses to “How much sleep did you get last night?” and (2) the
difference between SL, WASO, and EMA from the reported TIB
(compute TST = TIB – [SL + WASO + EMA]). Average weekly Total
Wake Time (TWT) was also estimated using the sum of sleep
latency, wake after sleep onset, and early morning awakenings
(TWT = SL + WASO + EMA). Participants completed their diaries
using a study-dedicated online portal. Participants received
daily email reminders to complete their sleep diaries and email
notification if they missed a diary entry. If a participant missed
a diary, it would be recorded as a missed entry (i.e. there was no
option to retrospectively complete diary entries).
Stressful life events. Stressful life events were measured using
an updated version of the Social Readjustment Rating Scale
[29]. Participants completed the measure on a weekly basis
by identifying stressful life events that they had experienced
within the previous week. Each of the 43 life events listed are
coded with a value proportionate to the level of stress typically resulting from the event (e.g. “divorce” has a value of 73,
whereas “taking a loan” has a value of 17). These values were
estimated using the average distress score (0–100) from a convenience sample and validated in a representative sample [30].
Total scores represent the sum of the values for all events experienced by an individual within that week.

Statistical analyses
In the present study, we operationalized acute insomnia in two
ways. For the first set of analyses, we were interested in the link
between sleep reactivity and the incidence of acute insomnia.
In this case, we operationalized acute insomnia using the “diagnostic” definition of the condition (i.e. greater than 30 min for at
least 3 nights per week on any of the insomnia subtypes – SL,
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Subject attrition. A total of 3,287 participants were positively
screened for good sleep and entered Phase-1 (consent, baseline
questionnaires and two weeks of daily sleep diaries). 85 participants (2.6%) were disenrolled due to noncompliance during the
2-week baseline assessment (daily diaries). Of the remaining
3,202 participants that completed the baseline assessment and
entered Phase-2 of the study, 1,954 participants (59.4%) were excluded from our final analyses. Of the 1,954 participants that
were excluded in Phase-2, 926 participants were excluded for
not meeting the 60% adherence threshold and 1,028 participants
were excluded for meeting criteria for AI (i.e. they did not enter
the study as good sleepers). A total of 1,246 participants (38.0%)
entered and completed Phase-2. Of those, 21 participants did
not have sleep reactivity (i.e. FIRST; Ford Insomnia Response to
Stress Test) data and were therefore excluded from the current
analyses. The final sample consisted of 1,225 participants.

situation recently. The FIRST has been widely used in previous
sleep research [12, 15, 25, 26], and has demonstrated good psychometric properties. In the present study, the measure demonstrated good internal consistency (Cronbach’s alpha = 0.88). The
total score was equal to the sum of the nine items, with higher
scores suggesting greater sleep reactivity. Clinical cut-offs for
the FIRST were also recently proposed [27]. Based on these recommendations, the present study used a cut-off score of 16 or
greater to define “high” sleep reactivity.
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“high sleep reactivity.” [34] To draw more clinically meaningful
conclusions, the sleep reactivity scores were also analyzed as a
categorical measure with FIRST scores greater than or equal to
16 coded as high sleep reactivity and scores below 16 coded as
low first reactivity.

Results
Descriptive statistics
The mean FIRST score for participants in the sample was 16.7
(SD = 5.7), with 53% of the sample reporting “high sleep reactivity” (a score ≥ 16). High FIRST scores were greater among
women (mean = 17.5) relative to men (mean = 14.9, r = 0.22, p
< .001). Of the female participants in the sample, 59% of them
reported a high FIRST score (compared to 39% among men).
The means and standard deviations for all study variables are
reported in Table 1. When comparing participants who scored
high versus low on the sleep reactivity measure, participants
with high FIRST scores reported greater TWT (high FIRST, median = 18.0 min, IQR = 19.8; low FIRST, median = 14.6, IQR = 17.7;
p < .001).

Does sleep reactivity increase risk/incidence of acute
insomnia?
When FIRST scores were treated as a continuous variable, results from the logistic regression supported that greater sleep

Table 1. Measures of central tendency, variance, frequency, and percentages for all study variables sorted by: total sample, participants with
high sleep reactivity (as assessed by FIRST), and participants with low sleep reactivity; effect size (n2) and corresponding statistical significance
were also included.

Stressful life events, Median (IQR)
TWT, Median (IQR)
AGE, Mean (SD)
BMI, Mean (SD)
GENDER, n (%)
Female, n (%)
Male, n (%)
RACE, n (%)
American Indian/Alaskan Native
Asian American
Native Hawaiian/Pacific Islander
Black
White
Multi-Racial
Unknown
HISPANIC, n (%)
Non-Hispanic
Hispanic
Education, n (%)
HS or less
More than HS
Annual income, n (%)
Less than $30K
Greater than or equal to $30K

Total sample

High FIRST

Low FIRST

(n = 1,225)

(n = 643)

(n = 582)

P-value

n2

0 (13.0)
16.4 (18.7)
53.2 (11.0)
28.9 (7.4)

0.0 (20.0)
18.2 (19.7)
52.8 (11.0)
28.7 (7.5)

0.0 (0.0)
14.7 (17.7)
53.8 (11.0)
29.0 (7.3)

<.001
<.001
.03
.50
<.001

<0.001
0.012
0.001
<0.001
0.034

831 (67.8)
392 (32.0)

489 (76.2)
153 (23.8)

342 (58.9)
239 (41.1)
.01

<0.001

11 (0.9)
28 (2.3)
2 (0.2)
86 (7.0)
1,019 (83.2)
29 (2.4)
50 (4.1)

7 (1.1)
20 (3.1)
0.0 (0)
38 (5.9)
538 (83.7)
9 (1.4)
31 (4.8)

4 (0.7)
8 (1.4)
2 (0.3)
48 (8.2)
481 (82.6)
20 (3.4)
19 (3.4)
.19

0.001

1,171 (95.6)
54 (4.4)

610 (94.9)
33 (5.1)

561 (96.4)
21 (3.6)
.62

<0.001

147 (12.0)
1076 (87.8)

80 (12.5)
562 (87.5)

67 (11.5)
514 (88.5)
.76

<0.001

269 (22.0)
954 (77.9)

139 (21.7)
503 (78.3)

130 (22.4)
451 (77.6)

Note. IQR and SD are used to represent interquartile ranges and standard deviation, respectively. Stressful Life Events = LES scores, TWT = total wake time, BMI = body
mass index.
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WASO, or EMA). Specifically, we used moving 14-day windows
(first window consisted of days 1–14, second window consisted
of days 2–15, third window consisted of days 3–16, etc.) to determine whether a participant met criteria for acute insomnia.
Logistic regression analyses were used to quantify whether
sleep reactivity predicted incidence of acute insomnia (yes/no
for any episode across the 1-year study period). In the second set
of analyses (mixed effects models), we examined whether sleep
reactivity was related to relative differences in week-to-week
levels of insomnia. To maximize variability in weekly “sleeplessness” and considering that patients with insomnia may
experience any combination of SL/WASO/EMA, we operationalized insomnia symptoms as TWT (or the sum of SL/WASO/
EMA). TWT has been previously used as a method to estimate
insomnia or sleep continuity disturbance [31–33]. A series of
mixed-effects models (via SPSS MIXED 26.0) were used to assess whether stressful life events were associated with average
TWT, and whether this association varied as a function of sleep
reactivity scores. Due to a positively skewed distribution, weekly
stress scores were log transformed and person mean-centered.
Sleep reactivity scores were grand mean-centered to aide interpretation of the output. For the mixed-effects models, average
weekly TWT was entered as the dependent variable. Weekly
stress scores, sleep reactivity scores, and the two-way interaction between stressful life events and sleep reactivity were
entered as fixed effects. The intercept was entered as a random
effect to control for clustering in the data (i.e. within subject
variability in TWT). Clinical cut-offs for sleep reactivity were recently proposed, with sleep reactivity scores ≥ 16 categorized as
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Does sleep reactivity moderate the link between weekly
stressful life events and insomnia symptoms?
As expected, there was a significant main effect of weekly
stressful life events on average weekly total wake time (TWT,
b = 1.49, 95% CI = 1.30–1.69, t = 14.8, p < .001) in the full sample.
Such that, greater stressful life events were related to greater
overall insomnia symptoms. Next, we assessed whether the
association between weekly stressful life events and TWT
varied as a function of sleep reactivity. Results supported that
FIRST scores significantly moderated the association between

stressful life events and TWT, two-way interaction, b = 0.08, 95%
CI = 0.05–0.12, t = 4.50, p < .001. Specifically, the impact of weekly
stressful life events on TWT was greater at higher levels of FIRST
(see Figure 2). Because stressful life events were person meancentered, these data represent the effect of experiencing more
stressful life events relative to each participant’s mean level
of stress (i.e. controls for within-subject differences in stress).
When analyzing the FIRST data categorically, results were
similar, the association between weekly stressful life events
and TWT were significantly greater among participants who reported high sleep reactivity, two-way interaction, b = 0.42, 95%
CI = 0.18–0.81, t = 2.05, p = .04. Specifically, among participants
with high sleep reactivity the association between weekly LES
and TWT was greater, b = 1.72, 95% CI = 1.44–2.00, t = 11.99,
p < .001, relative to participants with low sleep reactivity, b = 1.29,
95% CI = 1.03–1.56, t = 9.56, p < .001. We also re-analyzed the data
after person mean-centering the outcome variable (TWT). This
output provides more information related to within-subject effects by assessing whether relative increases in stressful life
events (from each participant’s average levels of stress) are
related to relative increases in TWT (from each participant’s
average levels of TWT). These data further confirmed that relative elevations in stressful life events were related to corresponding elevations in TWT and that this was particularly true
for participants with greater sleep reactivity (continuous variable), two-way interaction, b = 0.08, 95% CI = 0.05–0.12, t = 4.50,
p < .001 (Figure 3). Please see Table 2 for a summary of all the
model estimates.

Figure 1. Differences between high and low sleep reactivity in participants who remained good sleepers throughout the one year of data collection versus participants
who developed new onset acute insomnia during that time interval. High Sleep Reactivity represents FIRST scores ≥ 16, Low Sleep Reactivity represents FIRST scores
< 16.
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reactivity was associated with a greater likelihood of developing
acute insomnia during the one-year interval (OR = 1.05, 95%
CI = 1.02–1.07, p < .001). This effect remained significant even
while controlling for gender (OR = 1.04, 95% CI = 1.02–1.06,
p = .001). These data indicate that for every unit increase in FIRST,
there was approximately 4% increased odds of developing acute
insomnia. When FIRST scores were treated as a categorical variable and gender was entered as a covariate, results supported
that the high sleep reactivity group, compared to the low sleep
reactivity group, was at 76% greater odds of developing acute
insomnia during the study period (OR = 1.76, 95% CI = 1.35–2.29,
p < .001). In this sample, 20.6% of low FIRST participants developed acute insomnia and 32.8% of high FIRST participants developed acute insomnia. Another way to interpret this is that
63.7% of participants with acute insomnia had high FIRST scores
(see Figure 1).

6 | SLEEP, 2022, Vol. XX, No. XX

Figure 3. Model-based estimated from two-way interaction between FIRST scores and stressful life events on weekly deviations in TWT. This figure represents average
deviation (from each person’s mean levels) in TWT based on different levels of stress among participants with high and low sleep reactivity. Stressful life events represent relative deviations in stress from each person’s own mean levels. Error bars were estimated using 95% confidence intervals.
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Figure 2. Model-based estimated from two-way interaction between FIRST scores and stressful life events on TWT. This figure represents differences in average total
wake time based on varying levels of stressful life events (LE) among participants with high and low sleep reactivity. Stressful life events represent relative deviations
in stress from each person’s own mean levels. Error bars were estimated using 95% confidence intervals.
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Table 2. Regression estimates from models assessing the effects of stressful life events and sleep reactivity (FIRST) on total wake time (TWT).
First scores were coded both as a continuous variable (Model 1) and a categorical variable (Model 2). For Model 2, beta coefficients for main
effect and two-way interactions for FIRST represent relative change in TWT for high sleep reactive participants compared to low sleep reactive
participants (i.e. Low FIRST as reference group).
95% Confidence Interval

1.49
0.43
0.08

1.30
0.31
0.05

1.69
0.54
0.12

<.001
<.001
<.001

1.30
4.29
0.42

1.00
2.98
0.18

1.60
5.60
0.81

<.001
<.001
.04

Discussion
The sleep reactivity hypothesis of insomnia states that individuals with a greater vulnerability to stress-related sleep disturbance are more likely, when stressed, to experience sleeplessness
in the short term and are at greater risk for developing insomnia
disorder in the long term. While the relationship between sleep
reactivity and stress has been previously observed using prospective data, this is the first study to assess acute sleep continuity disturbance and stress simultaneously (with high density
sampling) over the course of an extended time interval. The goals
of the present study were to estimate whether sleep reactivity
(1) predicted the incidence of acute insomnia and (2) moderated
the association between greater stressful life events and greater
sleep continuity disturbance. As predicted, high sleep reactivity
was associated with a greater likelihood of developing acute insomnia. There was also a main effect of stressful life events on
total sleeplessness (i.e. TWT). That is, on weeks where participants reported high levels of stressful life events, they were also
more likely to endorse greater TWT. Findings also supported our
hypothesis that the relationship between greater stressful life
events and greater insomnia symptoms was stronger among
participants who endorsed high sleep reactivity.
As previously reported, the incidence rate of new-onset
acute insomnia in this sample was 27% per annum [20]. Among
those participants who developed acute insomnia, 64% reported
high sleep reactivity at baseline (compared to 48% among those
who remained good sleepers; see Figure 1). This finding is consistent with the three factor (3P) etiological model of insomnia
and supports that some individuals possess a lower threshold
for experiencing sleeplessness in the face of stress. Put differently, when stress (a precipitating factor) emerges, acute insomnia is more likely to occur in the presence of high sleep
reactivity (a predisposing factor). The results from the present
study are significant as they provide the first evidence that sleep
reactivity precedes and predicts acute insomnia, whereas previous studies have focused on its relation to insomnia disorder
(i.e. chronic insomnia). Not surprisingly, stressful life events, in
and of itself, predicted greater sleep continuity disturbance. This
finding aligns with research demonstrating that—even among
good sleepers—exposure to stressful events results in greater
nocturnal wakefulness (TWT) [16, 35, 36]. Findings from the current study also indicate that the effect of stressful life events
on sleep was stronger among participants with high sleep reactivity. That is, the results suggest that individuals with higher
sleep reactivity may be at an increased likelihood of developing

P-value

insomnia symptoms when they experience a greater number of
stressful life events. These individual differences further support
the perspective that there may be an underlying general vulnerability (predisposition) toward insomnia [24]. One possible explanation for this variability is that individuals with high sleep
reactivity are more susceptible to the effects of stress due to an
elevated basal level of physiologic arousal, increased arousal responding (i.e. greater amplitude), and/or extended arousal responding (i.e. longer duration). This phenomenon may be tied to
altered HPA-axis functioning, associated with increased evening
and nocturnal cortisol concentrations [37], higher resting heart
rate [38], reduction of slow wave and rapid eye movement sleep
[39], disruptions to the dopaminergic or serotonergic systems
[26], and/or “non-dipping” (i.e. lack of normal decline) in nocturnal blood pressure [40] in response to stress. Another possible
explanation is that highly sleep reactive individuals may experience cognitive hyperarousal in terms of intrusive thoughts, increased rumination, or simply elevated levels of mental activity
[41]. These phenomena may account for why sleep reactivity
confers a vulnerability for insomnia.
The current study has several important strengths and limitations to note. The strengths include: (1) the formal aggregation
of a good sleeper sample (using prospective and retrospective
corroboration of sleep status); (2) the focus on [new onset] acute
rather than chronic insomnia; (3) the use of a dense sampling
approach over a long monitoring interval (daily and weekly assessments for up to one year); (4) the study sample size; and
(5) the examination of sleep reactivity as a moderator between
stressful life events and insomnia, particularly in a good sleeper
sample where the measures were obtained prospectively.
Regarding the latter point, the use of a good sleeper sample
was ideal for testing the sleep reactivity model as it provides
a group of individuals who do not have a prior history of sleep
continuity disturbance. Therefore, their perceptions of the likelihood that they will experience insomnia during times of stress
are unbiased.
The limitations of the study include: (1) the high exclusion/
attrition rate that resulted from the loss of participants due to
ineligibility, noncompliance, withdrawal, disenrollment, and/
or removal from the dataset owing to the irregular completion
of sleep diaries; (2) the lack of diversity in the sample (i.e. the
sample was primarily white, female, and older); (3) the limited
scope by which stressful life events were assessed, and specifically, that we were not able to control for the duration of
each acute stressor that was endorsed (i.e. we did not assess
the onset/offset of each acute stressor) or the variability in how
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MODEL 1 (continuous)
Stressful life events
FIRST
Stressors × FIRST
MODEL 2 (categorical)
Stressful life events
FIRST
Stressors × FIRST
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